$OLMA SEC Filings

Filed On	Filing
16 Oct 2026	SCHEDULE 13D/A
15 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 12, 2026, Dr. Gorjan Hrustanovic notified Olema Pharmaceuticals, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors (the “Board”), effective October 14, 2026. Dr. Hrustanovic also resigned fro...
02 Sep 2026	Form 4: O'Byrne Jason, CHIEF FINANCIAL OFFICER Granted 650,000 Stock Option (Right to Buy)
13 Aug 2026	Form 3: O'Byrne Jason, CHIEF FINANCIAL OFFICER No securities owned
13 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
10 Aug 2026	10-Q
10 Aug 2026	8-K: Results of Operations and Financial Condition
06 Aug 2026	SCHEDULE 13G/A
29 Jul 2026	SCHEDULE 13G/A
27 Jul 2026	Form 4: Harmon Cyrus, Director Sold 12,500 shares ($145K) · Sold 12,500 shares ($146K)
24 Jul 2026	144
23 Jul 2026	144
23 Jun 2026	Form 4: Harmon Cyrus, Director Granted 29,500 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Butitta Cynthia M, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Garland J. Scott, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Hrustanovic Gorjan, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Clark Ian T, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Larson Yi, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Horning Sandra, Director Granted 29,500 Stock Option (right to buy)
23 Jun 2026	Form 4: Raman Prakash, Director Granted 29,500 Stock Option (right to buy)

Comments